FDA accepts Replimune RP1 BLA resubmission for advanced melanoma
Go back to FDA accepts Replimune RP1 BLA resubmission for advanced melanoma| Rider Explorations, Inc. (NASDAQ: REPL) | Delayed: 14.45 -0.32 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.77 | 52 Week High | $1.45 | |||
| Open | $14.54 | 52 Week Low | $0.50 | |||
| Day High | $14.76 | P/E | N/A | |||
| Day Low | $14.30 | EPS | $0.00 | |||
| Volume | 1,074,933 | |||||
